Viatorr覆膜支架在经颈静脉肝内门体分流术中的应用现状

丁智锋; 殷世武

doi:10.3969/j.issn.1001-5256.2018.05.039

Viatorr覆膜支架在经颈静脉肝内门体分流术中的应用现状

DOI: 10.3969/j.issn.1001-5256.2018.05.039

安徽医科大学附属合肥医院介入与血管外科

基金项目:

合肥市科技局基金(YW201512010005)；

详细信息

中图分类号: R657.3
计量
- 文章访问数: 2337
- HTML全文浏览量: 40
- PDF下载量: 411
- 被引次数: 0
出版历程
- 出版日期: 2018-05-20

Application of Viatorr covered stent in transjugular intrahepatic portosystemic shunt

Department of Vascular Intervention, Hefei Hospital Affiliated to Anhui Medical University, Hefei 230000, China

Research funding:

摘要

摘要:
经颈静脉肝内门体分流术(TIPS)已广泛应用于治疗门静脉高压并发症,近年来随着对于TIPS认识程度的加深,覆膜支架得到更进一步的发展应用,其中TIPS专用支架(Viatorr覆膜支架)更是成为关注的焦点。综述了Viatorr覆膜支架的应用与效果,指出采用Viatorr覆膜支架建立肝内分流通道能够明显提高分流道通畅率,在未增加肝性脑病的发生率的同时减少了重复干预及再出血的风险,使患者的生活质量得到提高。
- 肝硬化 /
- 高血压,门静脉 /
- 门体分流术,经颈静脉肝内 /
- Viatorr支架
Abstract:
Transjugular intrahepatic portosystemic shunt ( TIPS) has been widely used in the treatment of the complications of portal hypertension, and in recent years, with a deepened understanding of TIPS, covered stents have been further developed and applied in clinical practice, among which a special stent for TIPS, Viatorr covered stent, has become a focus of attention. This article reviews the application and effect of Viatorr stent and points out that Viatorr stent can establish intrahepatic shunt and thus significantly improve shunt patency rate.Meanwhile, it can reduce the risk of repeated intervention and rebleeding without increasing the incidence rate of hepatic encephalopathy and improve patients' quality of life.
- liver cirrhosis /
- hypertension, portal /
- portasystemic shunt, transjugular intrahepatic /
- Viatorr cover stent

HTML全文

参考文献(40)

[1]GARCIA-TSAO G, ABRALDES J, BERZIGOTTI A, et al.Portal hypertensive bleeding in cirrhosis:risk stratification, diagnosis and management-2016 practice guidance by the American Association for the Study of Liver Diseases[J].Hepatology, 2017, 65 (1) :310-335.

[2]ZHAO HW, QI RZ, YUE ZD, et al.Analysis of technical difficulties of transjugular intrahepatic portosystemic shunt in 3 367 patients[J].Chin J Dig Surg, 2016, 15 (7) :689-695. (in Chinese) 赵洪伟, 齐瑞兆, 岳振东, 等.3367例经颈静脉肝内门体分流术的技术难点分析[J].中华消化外科杂志, 2016, 15 (7) :689-695.

[3]RSSLE M.TIPS:25 years later[J].J Hepatol, 2013, 59 (5) :1081-1093.

[4]RICHTER GM, PALMAZ JC, NLDGE G, et al.The transjugular intrahepatic portosystemic stent-shunt.A new nonsurgical percutaneous method[J].Radiologe, 1989, 29 (8) :406-411.

[5]JUNG HS, KALVA SP, GREENFIELD AJ, et al.TIPS:comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts[J].J Vasc Interv Radiol, 2009, 20 (2) :180-185.

[6]TRIPATHI D, FERGUSON J, BARKELL H, et al.Improved clinical outcome with transjugular intrahepatic portosystemic stentshunt utilizing polytetrafluoroethylene-covered stents[J].Eur J Gastroenterol Hepatol, 2006, 18 (3) :225-232.

[7]BAO YJ, GU JP, REN WX.The application of the Fluency covered stents in current clinical practice of TIPS[J].J Intervent Radiol, 2014, 23 (4) :357-359. (in Chinese) 鲍应军, 顾俊鹏, 任伟新.Fluency覆膜支架在TIPS中的应用现状[J].介入放射学杂志, 2014, 23 (4) :357-359.

[8]LI SW, LI YC, YAN D, et al.Transjugular intrahepatic portosystemic shunt with Fluency covered stent:analysis of the causes of stent stenosis[J].J Intervent Radiol, 2015, 24 (12) :1047-1051. (in Chinese) 李松蔚, 李迎春, 闫东, 等.Fluency覆膜支架行TIPS术后支架狭窄原因分析[J].介入放射学杂志, 2015, 24 (12) :1047-1051.

[9]SAAD WE, DARWISH WM, DAVIES MG, et al.Stent-grafts for transjugular intrahepatic portosystemic shunt creation:specialized TIPS stent-graft versus generic stent-graft/bare stent combination[J].J Vasc Interv Radiol, 2010, 21 (10) :1512-1520.

[10]LI CQ, LI HL, GUO J, et al.Application of simulative Viatorr technique in TIPS with double stents[J/CD].Chin J Liver Dis:Electronic Edition, 2014, 6 (1) :50-54. (in Chinese) 李常青, 李洪璐, 郭江, 等.双支架技术在TIPS治疗中的临床应用研究[J/CD].中国肝脏病杂志:电子版, 2014, 6 (1) :50-54.

[11]HAUSEGGER KA, KARNEL FB, TAUSS J, et al.Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft[J].J Vasc Interv Radiol, 2004, 15 (3) :239-248.

[12]CHEN H, LYU Y, WANG QH, et al.Expert consensus on transjugular intrahepatic portosystemic shunt[J].J Clin Hepatol, 2017, 33 (7) :1218-1228. (in Chinese) 陈辉, 吕勇, 王秋和, 等.经颈静脉肝内门体分流术专家共识[J].临床肝胆病杂志, 2017, 33 (7) :1218-1228.

[13]GEEROMS B, LALEMAN W, LAENEN A, et al.Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients:Long-term patency and clinical outcome results[J].Eur Radiol, 2017, 27 (5) :1795-1803.

[14]WEBER CN, NADOLSKI GJ, WHITE SB, et al.Long-term patency and clinical analysis of expanded polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunt stent grafts[J].J Vasc Interv Radiol, 2015, 26 (9) :1257-1265.

[15]PERARNAU JM, GOUGE AL, NICOLAS C, et al.Covered vs.uncovered stents for transjugular intrahepatic portosystemic shunt:a randomized controlled trial[J].J Hepatol, 2014, 60 (5) :962-968.

[16]QI X, HAN G, FAN D.Management of portal vein thrombosis in liver cirrhosis[J].Nat Rev Gastroenterol Hepatol, 2014, 11 (7) :435-446.

[17]MURA VL, BRAHAM S, TOSETTI G, et al.Harmful and beneficial effects of anti-coagulants in patients with cirrhosis and portal vein thrombosis[J].Clin Gastroenterol Hepatol, 2017.[Epub ahead of print]

[18] HAN GH, MENG XJ, YIN ZX, et al.Transjugular intrahepatic portosystemie shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation[J].Natl Med J China, 2009, 89 (22) :1549-1552. (in Chinese) 韩国宏, 孟祥杰, 殷占新, 等.经颈内静脉肝内门腔分流术及联合经皮肝/脾穿刺途径治疗门静脉血栓和 (或) 海绵样变性[J].中华医学杂志, 2009, 89 (22) :1549-1552.

[19]QI X, HE C, GUO W, et al.Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis:outcomes and predictors in a prospective cohort study[J].Liver Int, 2016, 36 (5) :667.

[20]FUJIYAMA S, SAITOH S, KAWAMURA Y, et al.Portal vein thrombosis in liver cirrhosis:incidence, management, and outcome[J].BMC Gastroenterol, 2017, 17 (1) :112.

[21]LV Y, QI X, HE C, et al.Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis:a randomised controlled trial[J].Gut, 2017.[Epub ahead of print]

[22]LUCA A, MIRAGLIA R, CARUSO S, et al.Short-and longterm effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis[J].Gut, 2011, 60 (6) :846-852.

[23]THORNBURG B, DESAI K, HICKEY R, et al.Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis:final analysis of a61-patient cohort[J].J Vasc Interv Radiol, 2017, 28 (12) :1714-1721.

[24]NARDELLI S, GIOIA S, PASQUALE C, et al.Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J].Am J Gastroenterol, 2016, 111 (4) :523-528.

[25]FONIO P, DISCALZI A, CALANDRI M, et al.Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification[J].Radiol Med, 2017, 122 (9) :713-721.

[26]BARRIO J, RIPOLL C, BAARES R, et al.Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.[J].Eur J Radiol, 2005, 55 (1) :120-124.

[27]ROSSI P, SALVATORI FM, FANELLI F, et al.Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation:3-year experience.[J].Radiology, 2004, 231 (3) :820-830.

[28]SOMMERA CM, STAMPFL U, BELLEMANN N, et al.Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt:bare metal stents (BMS) versus viatorr stent-grafts (VSG) [J].Eur J Radiol, 2012, 81 (9) :2273-2280.

[29]WU W, HE C, HAN G.Embolization of spontaneous splenorenal shunt for post-TIPS hepatic encephalopathy in a cirrhotic patient with variceal bleeding[J].Hepatology, 2014, 61 (5) :1761-1762.

[30]SRINIVASA RN, CHICK JFB, HAGE A, et al.Transjugular intrahepatic portosystemic shunt reduction using the gore viatorr controlled expansion endoprosthesis:hemodynamics of reducing an established 10-mm TIPS to 8-mm in diameter[J].Cardiovasc Intervent Radiol, 2017.[Epub ahead of print]

[31]WANG Q, LV Y, CHEN H, et al.Use of 8-mm covered tips:is“losses without gains”the end of the story?[J].Radiology, 2017, 284 (2) :604.

[32]RUNYON B A.Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012[J].Hepatology, 2013, 57 (4) :1651-1653.

[33]NARAHARA Y, KANAZAWA H, FUKUDA T, et al.Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function:a prospective randomized trial[J].J Gastroenterol, 2011, 46 (1) :78-85.

[34]BERCU ZL, FISCHMAN AM, KIM E, et al.TIPS for refractory ascites:a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts[J].AJR Am J Roentgenol, 2015, 204 (3) :654-661.

[35]MALEUX G, PEREZ-GUTIERREZ NA, MROUE A, et al.Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites:a retrospective cohort study[J].Acta Gastroenterol Belg, 2010, 73 (3) :336-341.

[36]TAN HK, JAMES PD, SNIDERMAN KW, et al.Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion[J].J Gastroenterol Hepatol, 2015, 30 (2) :389-395.

[37]ANGERMAYR B, CEJNA M, KOENIG F, et al.Survival in patients undergoing transjugular intrahepatic portosystemic shunt:e PTFE-covered stentgrafts versus bare stents[J].Hepatology, 2003, 38 (4) :1043-1050.

[38]GABA RC, OMENE BO, PODCZERWINSKI ES, et al.TIPS for treatment of variceal hemorrhage:clinical outcomes in 128 patients at a single institution over a 12-year period[J].J Vasc Interv Radiol, 2012, 23 (2) :227-235.

[39]BUCSICS T, SCHODER M, GOESCHL N, et al.Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice[J].Dig Liver Dis, 2017, 49 (12) :1360-1367.

[40]GUPTA AC, WANG W, SHAH C, et al.Added value of covered stents in transjugular intrahepatic portosystemic shunt:a large single-center experience[J].Cardiovasc Intervent Radiol, 2017, 40 (11) :1723-1731.

施引文献

资源附件(0)

访问统计